Medical Students' Evaluation of Dyslipidemia and LIPoprotein(a) Study (MEDLIP)

University of Ioannina

Status

Enrolling

Conditions

Insight Into the Prevalence of Elevated Lp(a) Among Greek Medical Students

Treatments

Diagnostic Test: Measurement of Lp(a) levels

Study type

Observational

Funder types

Other

Identifiers

NCT06482476

MEDLIP Study

Details and patient eligibility

About

This cross-sectional study aims to determine the prevalence of elevated Lp(a) levels among volunteer medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece. Data collected will include demographic information, family and medical history, as well as lifestyle habits, and the study aims to provide valuable insights into the prevalence of elevated Lp(a) among Greek medical students.

Full description

Lipoprotein(a) [Lp(a)] has emerged as a prevalent monogenetic cardiovascular risk factor globally. Despite its significance, clinical attention for elevated Lp(a) is suboptimal. This cross-sectional study aims to determine the prevalence of elevated Lp(a) levels among volunteer medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece, as well as gather data on the demographic characteristics and medical history of this population. Statistical analysis will assess Lp(a) levels, prevalence, and associations with demographic and cardiovascular risk factors. The study aims to provide valuable insights into the prevalence of elevated Lp(a) among Greek medical students, emphasizing the importance of awareness, early diagnosis, and management of this cardiovascular risk factor.

Enrollment

246 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria